HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laurence Lamant Selected Research

Cyclosporine (Ciclosporin)

8/2013Clonal cytophagic histiocytic panniculitis in children may be cured by cyclosporine A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laurence Lamant Research Topics

Disease

29Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2023 - 08/2003
27Neoplasms (Cancer)
01/2023 - 08/2004
20Melanoma (Melanoma, Malignant)
11/2022 - 05/2003
11Lymphoma (Lymphomas)
01/2023 - 05/2010
5Genetic Translocation (Chromosomal Translocation)
01/2022 - 03/2008
4Carcinogenesis
01/2019 - 10/2003
4Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2011 - 05/2006
3Neoplasm Metastasis (Metastasis)
11/2022 - 08/2008
3Hyperpigmentation
02/2020 - 01/2008
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2015 - 10/2003
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2014 - 11/2012
3T-Cell Lymphoma (Lymphoma, T Cell)
11/2012 - 05/2010
2Neurofibrosarcoma (MPNST)
12/2018 - 12/2017
2Nevus (Nevi)
01/2018 - 01/2015
2Disease Progression
01/2018 - 09/2009
2Panniculitis
01/2017 - 08/2013
2B-Cell Lymphoma (Lymphoma, B Cell)
09/2015 - 01/2014
2Hypersensitivity (Allergy)
06/2015 - 01/2014
2Chromosome Aberrations (Chromosome Abnormalities)
01/2015 - 08/2003
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
05/2010 - 01/2009
2Netherton Syndrome
03/2010 - 10/2003
1Pathologic Complete Response
01/2023
1Skin Manifestations
01/2023
1Peripheral Nervous System Diseases (PNS Diseases)
07/2022
1Residual Neoplasm
01/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2020
1Keratoacanthoma
12/2019
1Mouth Neoplasms (Oral Cancer)
11/2017
1Deafness (Deaf Mutism)
03/2017
1Keratosis
03/2017
1Ichthyosis (Xeroderma)
03/2017
1Allergic Contact Dermatitis
03/2017
1Angiolymphoid Hyperplasia with Eosinophilia
11/2015
1Burkitt Lymphoma (Burkitt's Lymphoma)
09/2015

Drug/Important Bio-Agent (IBA)

22Anaplastic Lymphoma KinaseIBA
01/2022 - 10/2003
12Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2003
6Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019 - 10/2003
5DNA (Deoxyribonucleic Acid)IBA
11/2022 - 09/2007
5MicroRNAs (MicroRNA)IBA
01/2019 - 06/2011
4CrizotinibIBA
01/2023 - 09/2015
4Messenger RNA (mRNA)IBA
06/2022 - 05/2010
4Phosphotransferases (Kinase)IBA
01/2021 - 01/2012
4Pyridinolcarbamate (P23)IBA
01/2019 - 08/2003
3Tyrosine Kinase InhibitorsIBA
01/2019 - 09/2015
3NucleophosminIBA
03/2018 - 08/2004
3Biomarkers (Surrogate Marker)IBA
01/2018 - 06/2015
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018 - 06/2015
3AntibodiesIBA
01/2018 - 05/2003
3VemurafenibIBA
01/2017 - 01/2012
3Methotrexate (Mexate)FDA LinkGeneric
11/2015 - 02/2009
3CytokinesIBA
05/2012 - 03/2010
2Immune Checkpoint InhibitorsIBA
01/2020 - 12/2015
2MART-1 AntigenIBA
12/2018 - 05/2003
2Brentuximab VedotinIBA
01/2017 - 11/2014
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2016 - 08/2013
2Monoclonal AntibodiesIBA
01/2016 - 10/2003
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2015 - 09/2009
2Cytarabine (Cytosar-U)FDA LinkGeneric
09/2015 - 01/2015
2Tyrosine (L-Tyrosine)FDA Link
08/2013 - 08/2004
2ChemokinesIBA
09/2012 - 05/2012
2Vinblastine (Vinblastine Sulfate)FDA Link
09/2010 - 10/2009
2ClathrinIBA
10/2003 - 05/2003
1Antigen-Antibody Complex (Immune Complex)IBA
01/2023
1B7-H1 AntigenIBA
06/2022
1A-Form DNA (A-DNA)IBA
01/2022
1GuanineIBA
01/2022
1Cell Surface ReceptorsIBA
01/2022
1Phosphates (Orthophosphate)IBA
01/2022
1CytosineIBA
01/2022
1Tacrolimus (Prograf)FDA LinkGeneric
02/2020
1sphingosine kinaseIBA
01/2020
1pembrolizumabIBA
12/2019
1Oncogene Proteins (Oncogene Protein)IBA
01/2019
1Monophenol Monooxygenase (Tyrosinase)IBA
12/2018
1S100 Proteins (S 100 Protein)IBA
12/2018
1Polycomb Repressive Complex 2IBA
12/2017
1methyl 5-aminolevulinateIBA
03/2017
1cobimetinibIBA
01/2017
1dabrafenibIBA
01/2017
1trametinibIBA
01/2017
1RNA (Ribonucleic Acid)IBA
01/2016
1Circulating MicroRNAIBA
01/2016
1Alkylating AgentsIBA
09/2015
1AnthracyclinesIBA
09/2015
1Rituximab (Mabthera)FDA Link
09/2015
1Transcription Factors (Transcription Factor)IBA
06/2015
1Paclitaxel (Taxol)FDA LinkGeneric
01/2015
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2015
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2015
1Fluorouracil (Carac)FDA LinkGeneric
01/2015
1regorafenibIBA
01/2015
1Histones (Histone)IBA
01/2014

Therapy/Procedure

9Therapeutics
07/2022 - 01/2008
8Drug Therapy (Chemotherapy)
01/2021 - 09/2010
1Drug Tapering
01/2023
1Lasers (Laser)
02/2020
1Ligation
01/2020
1Immunotherapy
01/2018
1Combination Drug Therapy (Combination Chemotherapy)
01/2017
1Radiotherapy
12/2015